DRDorit Ron

Dorit Ron

*This is an algorithmically generated author record based on publicly available information.

Dorit Ron has a total of 40 co-authors. Here are the top co-authors by number of shared publications:

  • Sami Ben Hamida

    Gallo Center at the Department of Neurology, University of California, San Francisco, San Francisco, California 94143, USA

    8 shared publications
  • Sebastien Carnicella

    Ernest Gallo Research Center and

    8 shared publications
  • Segev Barak

    Tel Aviv University

    7 shared publications
  • Jérémie Neasta

    IBMM, Univ Montpellier, CNRS, ENSCM Montpellier France

    6 shared publications
  • Jun Wang

    Department of Neuroscience and Experimental Therapeutics, Naresh K. Vashisht College of Medicine, Texas A&M University Health Science Center, Bryan, TX 77807, USA; Institute for Neuroscience, Texas A&M University, College Station, TX 77843, USA

    5 shared publications
  • Quinn V. Yowell

    Ernest Gallo Research Center, Department of Neurology, University of California, San Francisco, 5858 Horton street, suite 200, Emeryville, CA 94608

    5 shared publications

Latest Publications

  • Open Access

    Protein Tyrosine Phosphatase α in the Dorsomedial Striatum Promotes Excessive Ethanol-Drinking Behaviors

    by Sami Ben Hamida, Emmanuel Darcq, Jun Wang, Su Wu, Khanhky Phamluong, Viktor Kharazia, Dorit Ron

    We previously found that excessive ethanol drinking activates Fyn in the dorsomedial striatum (DMS) (Wang et al., 2010; Gibb et al., 2011). Ethanol-mediated Fyn activation in the DMS leads to the phosphorylation of the GluN2B subunit of the NMDA receptor, to the enhancement of the channel's activity, and to the development and/or maintenance of ethanol drinking behaviors (Wang et al., 2007, 2010). Protein tyrosine phosphatase α (PTPα) is essential for Fyn kinase activation (Bhandari et al., 1998), and we showed that ethanol-mediated Fyn activation is facilitated by the recruitment of PTPα to synaptic membranes, the compartment where Fyn resides (Gibb et al., 2011). Here we tested the hypothesis that PTPα in the DMS is part of the Fyn/GluN2B pathway and is thus a major contributor to the neuroadaptations underlying excessive ethanol intake behaviors. We found that RNA interference (RNAi)-mediated PTPα knockdown in the DMS reduces excessive ethanol intake and preference in rodents. Importantly, no alterations in water, saccharine/sucrose, or quinine intake were observed. Furthermore, downregulation of PTPα in the DMS of mice significantly reduces ethanol-mediated Fyn activation, GluN2B phosphorylation, and ethanol withdrawal-induced long-term facilitation of NMDAR activity without altering the intrinsic features of DMS neurons. Together, these results position PTPα upstream of Fyn within the DMS and demonstrate the important contribution of the phosphatase to the maladaptive synaptic changes that lead to excessive ethanol intake.


  • Open Access

    RACK(1) to the future – a historical perspective

    by Dorit Ron, David R Adams, George S Baillie, Aideen Long, Rosemary O’connor, Patrick A Kiely

    This perspective summarises the first and long overdue RACK1 meeting held at the University of Limerick, Ireland, May 2013, in which RACK1’s role in the immune system, the heart and the brain were discussed and its contribution to disease states such as cancer, cardiac hypertrophy and addiction were described. RACK1 is a scaffolding protein and a member of the WD repeat family of proteins. These proteins have a unique architectural assembly that facilitates protein anchoring and the stabilisation of protein activity. A large body of evidence is accumulating which is helping to define the versatile role of RACK1 in assembling and dismantling complex signaling pathways from the cell membrane to the nucleus in health and disease. In this commentary, we first provide a historical perspective on RACK1. We also address many of the pertinent and topical questions about this protein such as its role in transcription, epigenetics and translation, its cytoskeletal contribution and the merits of targeting RACK1 in disease.


  • Open Access

    Disruption of alcohol-related memories by mTORC1 inhibition prevents relapse

    by Segev Barak, Feng Liu, Sami Ben Hamida, Quinn V Yowell, Jeremie Neasta, Viktor Kharazia, Patricia H Janak, Dorit Ron

    The authors show that reconsolidation of alcohol-related memories activates mammalian target of rapamycin complex 1 (mTORC1) in select amygdalar and cortical regions and systemic or central amygdalar inhibition of mTORC1 during reconsolidation disrupts alcohol-associated memories, leading to a long-lasting suppression of relapse, suggesting a potential therapeutic target to prevent relapse. Relapse to alcohol abuse is an important clinical issue that is frequently caused by cue-induced drug craving. Therefore, disruption of the memory for the cue-alcohol association is expected to prevent relapse. It is increasingly accepted that memories become labile and erasable soon after their reactivation through retrieval during a memory reconsolidation process that depends on protein synthesis. Here we show that reconsolidation of alcohol-related memories triggered by the sensory properties of alcohol itself (odor and taste) activates mammalian target of rapamycin complex 1 (mTORC1) in select amygdalar and cortical regions in rats, resulting in increased levels of several synaptic proteins. Furthermore, systemic or central amygdalar inhibition of mTORC1 during reconsolidation disrupts alcohol-associated memories, leading to a long-lasting suppression of relapse. Our findings provide evidence that the mTORC1 pathway and its downstream substrates are crucial in alcohol-related memory reconsolidation and highlight this pathway as a therapeutic target to prevent relapse.


  • Open Access

    Chromatin remodeling — a novel strategy to control excessive alcohol drinking

    by V Warnault, E Darcq, A Levine, S Barak, D Ron

    Harmful excessive use of alcohol has a severe impact on society and it remains one of the major causes of morbidity and mortality in the population. However, mechanisms that underlie excessive alcohol consumption are still poorly understood, and thus available medications for alcohol use disorders are limited. Here, we report that changing the level of chromatin condensation by affecting DNA methylation or histone acetylation limits excessive alcohol drinking and seeking behaviors in rodents. Specifically, we show that decreasing DNA methylation by inhibiting the activity of DNA methyltransferase (DNMT) with systemic administration of the FDA-approved drug, 5-azacitidine (5-AzaC) prevents excessive alcohol use in mice. Similarly, we find that increasing histone acetylation via systemic treatment with several histone deacetylase (HDAC) inhibitors reduces mice binge-like alcohol drinking. We further report that systemic administration of the FDA-approved HDAC inhibitor, SAHA, inhibits the motivation of rats to seek alcohol. Importantly, the actions of both DNMT and HDAC inhibitors are specific for alcohol, as no changes in saccharin or sucrose intake were observed. In line with these behavioral findings, we demonstrate that excessive alcohol drinking increases DNMT1 levels and reduces histone H4 acetylation in the nucleus accumbens (NAc) of rodents. Together, our findings illustrate that DNA methylation and histone acetylation control the level of excessive alcohol drinking and seeking behaviors in preclinical rodent models. Our study therefore highlights the possibility that DNMT and HDAC inhibitors can be used to treat harmful alcohol abuse.


  • Open Access

    Dopamine D2 receptor activation leads to an up‐regulation of glial cell line–derived neurotrophic factor via Gβγ‐Erk1/2‐dependent induction of Zif268

    by Somayeh Ahmadiantehrani, Dorit Ron

    Glial cell line–derived neurotrophic factor (GDNF) is a potent growth factor essential to the development, survival, and function of dopaminergic neurons (Airaksinen and Saarma 2002). The molecular mechanisms underlying GDNF expression remain elusive; thus, we set out to identify a signaling pathway that governs GDNF levels. We found that treatment of both differentiated dopaminergic‐like SH‐SY5Y cells and rat midbrain slices with the dopamine D2 receptor (D2R) agonist, quinpirole, triggered an increase in the expression of GDNF that was temporally preceded by an increase in the levels of zinc‐finger protein 268 (Zif268), a DNA‐binding transcription factor encoded by an immediate‐early gene. Moreover, the D2R inhibitor raclopride blocked the increase of both GDNF and Zif268 expression following potassium‐evoked dopamine release in SH‐SY5Y cells. We used adenoviral delivery of small hairpin RNA (shRNA) targeting Zif268 to down‐regulate its expression and found that Zif268 is specifically required for the D2R‐mediated up‐regulation of GDNF. Furthermore, the D2R‐mediated induction of GDNF and Zif268 expression was dependent on Gβγ‐mediated signaling and activation of extracellular signal–regulated kinase 1/2. Importantly, using chromatin immunoprecipitation assay, we identified a direct association of Zif268 with the GDNF promoter. These results suggest that D2R activation induces a Gβγ‐ and extracellular signal–regulated kinase 1/2‐dependent increase in the level of Zif268, which functions to directly up‐regulate the expression of GDNF.


  • GDNF is a novel ethanol‐responsive gene in the VTA: implications for the development and persistence of excessive drinking

    by Somayeh Ahmadiantehrani, Segev Barak, Dorit Ron

    Glial cell line‐derived neurotrophic factor (GDNF) is a potent inhibitor of ethanol consumption and relapse, and GDNF heterozygous knockout mice display increased reward sensitivity to ethanol and consume more ethanol after a period of abstinence than their wild‐type littermates. Here, we tested whether ethanol alters GDNF expression in the ventral tegmental area (VTA; GDNF's site of action) and/or the nucleus accumbens (NAc; the main source of GDNF), and if so, determine the role of the endogenous growth factor in the regulation of ethanol consumption. Systemic administration of ethanol increased GDNF expression and protein levels in the VTA, but not the NAc. Additionally, GDNF levels were elevated after an ethanol‐drinking session in rats that consumed ethanol in the intermittent‐access two‐bottle choice procedure for 1 week, but not 7 weeks. Deprivation following 7 weeks of excessive ethanol intake reduced GDNF levels, while a short ethanol binge drinking period following deprivation upregulated GDNF expression. Importantly, knockdown of GDNF within the VTA using adenovirus expressing short hairpin RNA facilitated the escalation of ethanol drinking by ethanol‐naïve rats, but not by rats with a history of excessive ethanol consumption. These results suggest that during initial ethanol‐drinking experiences, GDNF in the VTA is increased and protects against the development of excessive ethanol intake. However, the growth factor's protective response to ethanol breaks down after protracted excessive ethanol intake and withdrawal, resulting in persistent, excessive ethanol consumption.


  • BDNF‐mediated regulation of ethanol consumption requires the activation of theMAPkinase pathway and protein synthesis

    by Jerome Jeanblanc, Marian L. Logrip, Patricia H. Janak, Dorit Ron

    We previously found that the brain‐derived neurotrophic factor (BDNF) in the dorsolateral striatum (DLS) is part of a homeostatic pathway that gates ethanol self‐administration [Jeanblancet al. (2009).J Neurosci,29, 13494–13502)]. Specifically, we showed that moderate levels (10%) of ethanol consumption increaseBDNFexpression within theDLS, and that direct infusion ofBDNFinto theDLSdecreases operant self‐administration of a 10% ethanol solution.BDNFbinding to its receptor, TrkB, activates the mitogen‐activated protein kinase (MAPK), phospholipase C‐γ (PLC‐γ) and phosphatidylinositol 3‐kinase (PI3K) pathways. Thus, here, we set out to identify which of these intracellular pathway(s) plays a role in the regulation of ethanol consumption byBDNF. We found that inhibition of theMAPK, but notPLC‐γ orPI3K, activity blocks theBDNF‐mediated reduction of ethanol consumption. As activation of theMAPKpathway leads to the initiation of transcription and/or translation events, we tested whether theBDNF‐mediated reduction of ethanol self‐administration requiresde novoprotein synthesis. We found that the inhibitory effect ofBDNFon ethanol intake is blocked by the protein synthesis inhibitor cycloheximide. Together, our results show thatBDNFattenuates ethanol drinking via activation of theMAPKpathway in a protein synthesis‐dependent manner within theDLS.


  • Open Access

    The Small G Protein H-Ras in the Mesolimbic System Is a Molecular Gateway to Alcohol-Seeking and Excessive Drinking Behaviors

    by Sami Ben Hamida, Jeremie Neasta, Amy W. Lasek, Viktor Kharazia, Mimi Zou, Sebastien Carnicella, Patricia H. Janak, Dorit Ron

    Uncontrolled consumption of alcohol is a hallmark of alcohol abuse disorders; however, the central molecular mechanisms underlying excessive alcohol consumption are still unclear. Here, we report that the GTP binding protein, H-Ras in the nucleus accumbens (NAc) plays a key role in neuroadaptations that underlie excessive alcohol-drinking behaviors. Specifically, acute (15 min) systemic administration of alcohol (2.5 g/kg) leads to the activation of H-Ras in the NAc of mice, which is observed even 24 h later. Similarly, rat operant self-administration of alcohol (20%) also results in the activation of H-Ras in the NAc. Using the same procedures, we provide evidence suggesting that the exchange factor GRF1 is upstream of H-Ras activation by alcohol. Importantly, we show that infection of mice NAc with lentivirus expressing a short hairpin RNA that targets the H-Ras gene produces a significant reduction of voluntary consumption of 20% alcohol. In contrast, knockdown of H-Ras in the NAc of mice did not alter water, quinine, and saccharin intake. Furthermore, using two-bottle choice and operant self-administration procedures, we show that inhibiting H-Ras activity by intra-NAc infusion of the farnesyltransferase inhibitor, FTI-276, produced a robust decrease of rats' alcohol drinking; however, sucrose consumption was unaltered. Finally, intra-NAc infusion of FTI-276 also resulted in an attenuation of seeking for alcohol. Together, these results position H-Ras as a central molecular mediator of alcohol's actions within the mesolimbic system and put forward the potential value of the enzyme as a novel target to treat alcohol use disorders.


  • Open Access

    Ethanol-Mediated Facilitation of AMPA Receptor Function in the Dorsomedial Striatum: Implications for Alcohol Drinking Behavior

    by Jun Wang, Sami Ben Hamida, Emmanuel Darcq, Wenheng Zhu, Stuart L. Gibb, Maria Fe Lanfranco, Sebastien Carnicella, Dorit Ron

    We found previously that acuteex vivoas well as repeated cycles ofin vivoethanol exposure and withdrawal, including excessive voluntary consumption of ethanol, produces a long-lasting increase in the activity of NR2B-containing NMDA receptors (NR2B-NMDARs) in the dorsomedial striatum (DMS) of rats (Wang et al., 2010a). Activation of NMDARs is required for the induction of long-term potentiation (LTP) of AMPA receptor (AMPAR)-mediated synaptic response. We therefore examined whether the ethanol-mediated upregulation of NMDAR activity alters the induction of LTP in the DMS. We found thatex vivoacute exposure of striatal slices to, and withdrawal from, ethanol facilitates the induction of LTP in DMS neurons, which is abolished by the inhibition of NR2B-NMDARs. We also report that repeated systemic administration of ethanol causes an NR2B-NMDAR-dependent facilitation of LTP in the DMS. LTP is mediated by the insertion of AMPAR subunits into the synaptic membrane, and we found that repeated systemic administration of ethanol, as well as cycles of excessive ethanol consumption and withdrawal, produced a long-lasting increase in synaptic localization of the GluR1 and GluR2 subunits of AMPARs in the DMS. Importantly, we report that inhibition of AMPARs in the DMS attenuates operant self-administration of ethanol, but not of sucrose. Together, our data suggest that aberrant synaptic plasticity in the DMS induced by repeated cycles of ethanol exposure and withdrawal contributes to the molecular mechanisms underlying the development and/or maintenance of excessive ethanol consumption.